HUP0000411A2 - Porc- és csontnövekedést serkentő anyagok - Google Patents
Porc- és csontnövekedést serkentő anyagokInfo
- Publication number
- HUP0000411A2 HUP0000411A2 HU0000411A HUP0000411A HUP0000411A2 HU P0000411 A2 HUP0000411 A2 HU P0000411A2 HU 0000411 A HU0000411 A HU 0000411A HU P0000411 A HUP0000411 A HU P0000411A HU P0000411 A2 HUP0000411 A2 HU P0000411A2
- Authority
- HU
- Hungary
- Prior art keywords
- bone
- cartilage
- poly
- morphogenesis
- morphogenetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30756—Cartilage endoprostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/3006—Properties of materials and coating materials
- A61F2002/30062—(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
A találmány tárgyát porc és csont morfogenetikus javítását elősegítőanyagok képezik, amelyek alkalmasak csonttörés és csontkárosodáskezelésére. Közelebbről, a találmány tárgyát olyan porc és csontmorfogenetikus javítását elősegítő anyagok képezik, amelyek poli(oxi-etilén)-poli(oxi-propilénglikol)-t és csont morfogenezisét elősegítőfehérjét tartalmaznak, és amelyekben előnyösen a poli(oxi-etilén)-poli(oxi-propilénglikol) alkotóelemként 1500 és 4000 közöttimolekulatömegű polipropilénglikolt, valamint molekulánként mintegy 40-80% arányban etilén-oxidot tartalmaz, és a poli(oxi-etilén)- poli(oxi-propilénglikol) vizes oldatban van jelen és koncentrációja mintegy 10-50%. A találmány szerinti, porc és csont morfogenetikus javításátelősegítő anyag alkalmas porc és csont morfogenezisének kiváltására,anélkül hogy sebészeti műtétre lenne szükség. A találmány szerintiporc és csont morfogenetikus javítását elősegítő anyagra jellemző,hogy a csont morfogenezisét elősegítő fehérjén kívül egy olyanhordozót is tartalmaz, amelyre nagyfokú biabszorpció, a morfogenezistelősegítő fehérjével szembeni nagymértékű affinitás jellemző, valamintaz, hogy képes hőmérsékletfüggő, reverzíbilis szol-gél átmenetre, ígyalkalmas arra, hogy a csonttörés vagy csontkárosodás helyén alkalmazvahelyileg fejtse ki hatását. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7322402A JPH09143093A (ja) | 1995-11-17 | 1995-11-17 | 軟骨・骨誘導性修復用材料 |
PCT/JP1996/003333 WO1997018829A1 (fr) | 1995-11-17 | 1996-11-14 | Materiaux inducteurs d'os/de cartilage en vue de leur reparation |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0000411A2 true HUP0000411A2 (hu) | 2001-04-28 |
HUP0000411A3 HUP0000411A3 (en) | 2005-11-28 |
HU226201B1 HU226201B1 (en) | 2008-06-30 |
Family
ID=18143268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0000411A HU226201B1 (en) | 1995-11-17 | 1996-11-14 | Cartilage/bone inducing materials for reparation |
Country Status (19)
Country | Link |
---|---|
US (2) | US6903071B2 (hu) |
EP (1) | EP0884052B1 (hu) |
JP (1) | JPH09143093A (hu) |
KR (1) | KR100458413B1 (hu) |
CN (1) | CN1165340C (hu) |
AT (1) | ATE254470T1 (hu) |
AU (1) | AU712445C (hu) |
CA (1) | CA2235400C (hu) |
DE (1) | DE69630811T2 (hu) |
DK (1) | DK0884052T3 (hu) |
ES (1) | ES2211993T3 (hu) |
HK (1) | HK1018205A1 (hu) |
HU (1) | HU226201B1 (hu) |
NO (1) | NO325119B1 (hu) |
NZ (1) | NZ322188A (hu) |
PT (1) | PT884052E (hu) |
RU (1) | RU2180234C2 (hu) |
UA (1) | UA63896C2 (hu) |
WO (1) | WO1997018829A1 (hu) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09143093A (ja) * | 1995-11-17 | 1997-06-03 | Hoechst Japan Ltd | 軟骨・骨誘導性修復用材料 |
AU6267798A (en) † | 1997-02-07 | 1998-08-26 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
US6309659B1 (en) * | 1997-09-02 | 2001-10-30 | Gensci Orthobiologics, Inc. | Reverse phase connective tissue repair composition |
US9616150B2 (en) | 1999-10-29 | 2017-04-11 | Children's Hospital Los Angeles | Bone hemostasis method and materials |
ATE304870T1 (de) * | 1999-10-29 | 2005-10-15 | Los Angeles Childrens Hospital | Verfahren und material zur hämostase bei knochen |
WO2001036000A1 (en) | 1999-11-15 | 2001-05-25 | Bio Syntech Canada, Inc. | Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
US7747332B2 (en) * | 2000-05-08 | 2010-06-29 | International Rehabilitative Sciences, Inc. | Electrical stimulation combined with a biologic to increase osteogenesis |
MXPA03000203A (es) * | 2000-06-29 | 2004-09-13 | Biosyntech Canada Inc | Composicion y metodo para la reparacion y regeneracion del cartilago y otros tejidos. |
JP2002306163A (ja) * | 2001-04-11 | 2002-10-22 | Chemo Sero Therapeut Res Inst | 大腸菌を宿主とする遺伝子組換えヒトトロンビンの調製方法 |
US7205337B2 (en) * | 2001-12-21 | 2007-04-17 | Isotis Orthobiologics, Inc. | End-capped polymers and compositions containing such compounds |
CA2471403A1 (en) * | 2001-12-21 | 2003-07-10 | Gensci Orthobiologics, Inc. | End-capped polyalkylene glycols and compositions containing such compounds |
EP1512405B1 (en) * | 2002-05-20 | 2013-08-14 | Otsuka Pharmaceutical Co., Ltd. | Composition comprising adenosine monophosphate for treating melasma |
AU2002337479A1 (en) * | 2002-09-04 | 2004-03-29 | Hadasit Medical Research Services & Development Ltd. | Compositions comprising bone marrow cells, demineralized bone matrix and rtg polymers for use in the induction of bone and cartilage formation |
TW200507826A (en) | 2003-02-12 | 2005-03-01 | Ceremed Inc | Random alkylene oxide copolymers for medical and surgical utilities |
WO2007107012A1 (en) * | 2006-03-23 | 2007-09-27 | Citagenix Inc. | Reverse phase osteoconductive composition |
ES2402672T3 (es) * | 2007-01-25 | 2013-05-07 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Uso del GDF-5 para el mejoramiento o el mantenimiento del aspecto dérmico |
US8290780B2 (en) | 2009-06-24 | 2012-10-16 | International Business Machines Corporation | Dynamically extending the speech prompts of a multimodal application |
KR101405104B1 (ko) * | 2011-12-26 | 2014-06-10 | 한남대학교 산학협력단 | 약물의 서방형 방출 특성을 가지는 골 시멘트 |
US10743996B2 (en) * | 2017-03-24 | 2020-08-18 | Robert L. Bundy | Amnion putty for cartilage repair |
CN109125791B (zh) * | 2018-09-29 | 2019-08-30 | 广州贝奥吉因生物科技有限公司 | 一种具有促进骨修复功能的可吸收骨蜡及制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61277612A (ja) * | 1985-05-31 | 1986-12-08 | Kiyoshi Morikawa | 接種用徐放性組成物 |
JPH0723322B2 (ja) | 1985-12-07 | 1995-03-15 | 克之 藤井 | 液状骨形成剤からなる注射液 |
NZ226171A (en) * | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US4863732A (en) * | 1987-12-16 | 1989-09-05 | Collagen Corporation | Injectable composition for inductive bone repair |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
JPH045227A (ja) * | 1990-04-17 | 1992-01-09 | Pharmetrix Corp | 歯周疾患治療システム |
CA2040460C (en) * | 1990-05-01 | 1997-06-10 | Tacey X. Viegas | Drug delivery with thermoreversible gels |
CA2102808A1 (en) * | 1991-05-10 | 1992-11-11 | Hanne Bentz | Targeted delivery of bone growth factors |
MX9203083A (es) | 1991-06-21 | 1994-08-31 | Genetics Inst | Formulaciones farmaceuticas de proteinas osteogenicas. |
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
JPH08502082A (ja) * | 1992-07-02 | 1996-03-05 | コラーゲン コーポレイション | 生体適合性ポリマー結合体 |
IL110589A0 (en) * | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
JP3696265B2 (ja) * | 1994-02-04 | 2005-09-14 | 日本オルガノン株式会社 | 点鼻液剤 |
DE4423396C2 (de) | 1994-07-04 | 2001-10-25 | Fraunhofer Ges Forschung | Verfahren zum Herstellen einer mikromechanischen Oberflächenstruktur |
AU4652596A (en) * | 1995-01-09 | 1996-07-31 | Atrix Laboratories, Inc. | Liquid polymer delivery system |
US5902785A (en) * | 1995-06-06 | 1999-05-11 | Genetics Institute, Inc. | Cartilage induction by bone morphogenetic proteins |
JPH09143093A (ja) * | 1995-11-17 | 1997-06-03 | Hoechst Japan Ltd | 軟骨・骨誘導性修復用材料 |
-
1995
- 1995-11-17 JP JP7322402A patent/JPH09143093A/ja active Pending
-
1996
- 1996-11-14 UA UA98063095A patent/UA63896C2/uk unknown
- 1996-11-14 US US09/068,253 patent/US6903071B2/en not_active Expired - Fee Related
- 1996-11-14 DE DE69630811T patent/DE69630811T2/de not_active Expired - Lifetime
- 1996-11-14 WO PCT/JP1996/003333 patent/WO1997018829A1/ja active IP Right Grant
- 1996-11-14 HU HU0000411A patent/HU226201B1/hu not_active IP Right Cessation
- 1996-11-14 KR KR10-1998-0703705A patent/KR100458413B1/ko not_active IP Right Cessation
- 1996-11-14 ES ES96938460T patent/ES2211993T3/es not_active Expired - Lifetime
- 1996-11-14 DK DK96938460T patent/DK0884052T3/da active
- 1996-11-14 EP EP96938460A patent/EP0884052B1/en not_active Expired - Lifetime
- 1996-11-14 CN CNB961995645A patent/CN1165340C/zh not_active Expired - Fee Related
- 1996-11-14 AT AT96938460T patent/ATE254470T1/de active
- 1996-11-14 CA CA002235400A patent/CA2235400C/en not_active Expired - Fee Related
- 1996-11-14 PT PT96938460T patent/PT884052E/pt unknown
- 1996-11-14 RU RU98111599/14A patent/RU2180234C2/ru not_active IP Right Cessation
- 1996-11-14 AU AU75869/96A patent/AU712445C/en not_active Ceased
- 1996-11-14 NZ NZ322188A patent/NZ322188A/xx not_active IP Right Cessation
-
1998
- 1998-05-15 NO NO19982236A patent/NO325119B1/no not_active IP Right Cessation
-
1999
- 1999-07-23 HK HK99103183A patent/HK1018205A1/xx not_active IP Right Cessation
-
2004
- 2004-07-07 US US10/885,099 patent/US7238657B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HK1018205A1 (en) | 1999-12-17 |
NO325119B1 (no) | 2008-02-04 |
PT884052E (pt) | 2004-04-30 |
EP0884052B1 (en) | 2003-11-19 |
RU2180234C2 (ru) | 2002-03-10 |
DE69630811T2 (de) | 2004-06-17 |
US20020168381A1 (en) | 2002-11-14 |
DE69630811D1 (de) | 2003-12-24 |
HUP0000411A3 (en) | 2005-11-28 |
UA63896C2 (en) | 2004-02-16 |
CN1165340C (zh) | 2004-09-08 |
NO982236L (no) | 1998-06-26 |
US20050013864A1 (en) | 2005-01-20 |
EP0884052A1 (en) | 1998-12-16 |
NZ322188A (en) | 2000-10-27 |
KR19990067676A (ko) | 1999-08-25 |
HU226201B1 (en) | 2008-06-30 |
CN1207047A (zh) | 1999-02-03 |
ATE254470T1 (de) | 2003-12-15 |
AU712445C (en) | 2002-03-28 |
WO1997018829A1 (fr) | 1997-05-29 |
CA2235400C (en) | 2007-12-18 |
CA2235400A1 (en) | 1997-05-29 |
US6903071B2 (en) | 2005-06-07 |
KR100458413B1 (ko) | 2005-04-06 |
EP0884052A4 (en) | 1999-05-06 |
US7238657B2 (en) | 2007-07-03 |
ES2211993T3 (es) | 2004-07-16 |
DK0884052T3 (da) | 2004-03-29 |
NO982236D0 (no) | 1998-05-15 |
AU7586996A (en) | 1997-06-11 |
JPH09143093A (ja) | 1997-06-03 |
AU712445B2 (en) | 1999-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0000411A2 (hu) | Porc- és csontnövekedést serkentő anyagok | |
ATE400296T1 (de) | Zusammensetzungen und methoden zur stabilisierung von biologischen molekülen nach lyophilisierung | |
ES2210592T3 (es) | Compuestos con una mejorada actividad inductora de cartilago y/o hueso. | |
ATE252919T1 (de) | Zusammensetzungen und ihre verwendung zur verhütung von verklebungen zwischen körpergewebe | |
WO2001010907A3 (en) | Therapeutic polypeptides and methods for using same | |
BR0210282A (pt) | Veìculos de distribuição de fosfato de cálcio para proteìnas osteoindutivas | |
EP1140971A4 (en) | ANTISENS MODULATION OF NEW ANTI-APOPTOTIC BCL-2-LIKE PROTEINS | |
EP1548032A4 (en) | KDR-PEPTIDES AND VACCINES CONTAINING THEM | |
NL7601628A (nl) | Biologisch aanvaardbaar keramisch glas en toe- passing van het glas voor het vervaardigen van beenderprotesen, alsmede aldus verkregen protese. | |
BRPI0211200B8 (pt) | peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
ATE243198T1 (de) | Verbindungen mit leicht spaltbaren bindungen zur inaktivierung von pathogenen | |
ATE377657T1 (de) | Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung | |
ITPD920071A1 (it) | Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo | |
JP2011079862A (ja) | 第viii因子を含有する安定な医薬組成物 | |
RU98111599A (ru) | Материалы, стимулирующие рост хряща/кости, для препарата | |
DE69940635D1 (de) | Copolymer-zusammensetzungen zur oralen verabreichung | |
DE60211539D1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
ATE393573T1 (de) | Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren | |
ATE313628T1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
BRPI0407601A (pt) | molécula de ácido nucleico, plasmìdeo, composição farmacêutica, uso de nmolécula de ácido nucleico, e método de tratamento ou de prevenção de tumores | |
Szilágyi et al. | Specific reassociation of the polypeptide subunit chains of helical myosin fragments | |
Aldegheri et al. | Growth factors in Orthopaedics and in Traumatology. | |
Chang | Struktuur en funktie van humaan proteine S. | |
RU98103339A (ru) | Новые hmw человеческие mp52-белки | |
RU2001128806A (ru) | Способ стерилизации биологических трансплантатов окисью этилена в жидкой среде |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |